Gregory Fosheim
Subscribe to Gregory Fosheim's PostsGregory E. Fosheim advises healthcare and life sciences clients across a variety of corporate, transactional and regulatory compliance matters. Working with hospitals, physician practice groups, clinical research programs, pharmaceutical companies, device manufacturers and others, Greg provides counsel on healthcare fraud and abuse risks, Medicare, Medicaid, and private payor billing, and clinical research and laboratory compliance in connection with federal grants, among other issues. Greg also provides regulatory due diligence support on healthcare transactions and collaborations, helping his clients drive innovation and expand their businesses.
Read Gregory Fosheim’s full bio.
“Because of Bostock” – Court Delays HHS Rule Re-interpreting Section 1557 Discrimination “Because of Sex”
By Jacob Mattinson, Todd Solomon, Gregory Fosheim, Judith Wethall and Winnie Uluocha on Aug 25, 2020
Posted In Benefit Controversies, Employee Benefits, Health and Welfare Plans
One day before an updated rule of the US Department of Health and Human Services regarding Section 1557 of the Patient Protection and Affordable Care Act took effect, the US District Court for the Eastern District of New York ordered a stay and issued a preliminary injunction precluding the most recent final rules from becoming...
Continue Reading
HHS Finalizes Anti-Discrimination Revisions to ACA Section 1557
By Jacob Mattinson, Judith Wethall, Gregory Fosheim, Winnie Uluocha and Todd Solomon on Jul 14, 2020
Posted In Benefit Controversies, Health and Welfare Plans
On June 12, 2020, the Office for Civil Rights (OCR) of the US Department of Health and Human Services (HHS) finalized a rule under Section 1557 of the Patient Protection and Affordable Care Act (the 2020 Final Rule) that rescinds certain protections afforded to LGBTQ individuals and persons with limited English proficiency. At the same...
Continue Reading
